Alembic Pharmaceuticals gets FDA final approval for Paclitaxel Injection USP

Pallavi Madhiraju- October 27, 2022 0

Alembic Pharmaceuticals Limited has secured final approval for its abbreviated new drug application (ANDA) for Paclitaxel Injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 ... Read More

Gilead gets Trodelvy FDA priority review for pre-treated HR+/HER2- metastatic breast cancer

Pallavi Madhiraju- October 16, 2022 0

Gilead Sciences said that Trodelvy (sacituzumab govitecan-hziy) has been granted priority review from the US Food and Drug Administration (FDA) for the treatment of another ... Read More

AstraZeneca, Daiichi Sankyo get Enhertu FDA approval for HER2-low metastatic breast cancer

pallavi123- August 7, 2022 0

Enhertu FDA approval : AstraZeneca and Daiichi Sankyo have secured approval for Enhertu (trastuzumab deruxtecan) from the US Food and Drug Administration for the treatment ... Read More

BriaCell Therapeutics’ Bria-IMT gets FDA fast track status in breast cancer

pallavi123- April 15, 2022 0

BriaCell Therapeutics has secured the fast track status from the US Food and Drug Administration (FDA) for its lead candidate — Bria-IMT for the treatment ... Read More

Alphamab Oncology enrols patients for KN026-203 phase 2 clinical trial

pallavi123- January 15, 2022 0

Alphamab Oncology said that it has completed enrolling patients in China for its KN026-203 phase 2 clinical trial of the combination of KN026 and KN046 ... Read More

BCAL Diagnostics set to begin trading on ASX after raising $7.3m in IPO

Pallavi Madhiraju- July 21, 2021 0

BCAL Diagnostics is set to list on the Australian Securities Exchange (ASX) after an initial public offering that saw the Sydney-based breast cancer screening and ... Read More

ImmVira wraps up first dosing for MVR-T3011 in US and China

pallavi123- June 13, 2021 0

ImmVira said that it has wrapped up the first dosing of its oncolytic virus product - MVR-T3011 intratumoral injection in phase 2 clinical trials both ... Read More

Roche launches Elecsys Anti-p53 immunoassay to help in cancer diagnosis

Pallavi Madhiraju- April 11, 2021 0

Swiss healthcare company Roche has launched the Elecsys Anti-p53 immunoassay to help in the diagnosis of various types of cancer by the in vitro quantitative ... Read More

Olema Oncology to evaluate OP-1250, palbociclib combo in advanced breast cancer

pharmanewsdaily- November 15, 2020 0

Olema Oncology has entered into a clinical trial agreement with Pfizer to evaluate its small molecule OP-1250 in combination with the latter’s palbociclib (IBRANCE) in ... Read More

Merck to acquire US biopharma company VelosBio to strengthen oncology pipeline

pharmanewsdaily- November 8, 2020 0

Merck acquisition of VelosBio : US pharma giant Merck has agreed to acquire VelosBio, a California-based clinical-stage biopharma company, for $2.75 billion in an all-cash ... Read More